Bank of America Corp DE bought a new stake in shares of Calumet, Inc. (NASDAQ:CLMT - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 981,353 shares of the oil and gas company's stock, valued at approximately $35,348,000. Bank of America Corp DE owned about 1.12% of Calumet at the end of the most recent quarter.
Several other hedge funds have also made changes to their positions in CLMT. Jupiter Topco LLC bought a new stake in Calumet in the second quarter valued at $8,120,000. Legal & General Group Plc bought a new stake in shares of Calumet during the second quarter valued at approximately $1,734,000. The Manufacturers Life Insurance Company bought a new stake in shares of Calumet during the second quarter valued at approximately $1,075,000. Van Hulzen Asset Management LLC acquired a new position in shares of Calumet during the second quarter worth approximately $216,000. Finally, Cibc World Market Inc. acquired a new position in shares of Calumet during the second quarter worth approximately $287,000. Institutional investors own 34.41% of the company's stock.
Insiders Place Their Bets
In related news, Director Daniel Sajkowski sold 4,240 shares of the stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $36.16, for a total value of $153,318.40. Following the transaction, the director owned 77,718 shares in the company, valued at approximately $2,810,282.88. This represents a 5.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 3.15% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on CLMT shares. Weiss Ratings reiterated a "sell (d-)" rating on shares of Calumet in a research report on Friday, August 7th. The Goldman Sachs Group raised their price target on Calumet from $40.00 to $45.00 and gave the company a "neutral" rating in a report on Tuesday, August 18th. Citigroup reaffirmed a "buy" rating on shares of Calumet in a report on Monday, August 10th. HC Wainwright raised their price objective on shares of Calumet from $60.00 to $75.00 and gave the company a "buy" rating in a research note on Wednesday, September 2nd. Finally, TD Cowen raised their price objective on shares of Calumet from $34.00 to $40.00 and gave the company a "hold" rating in a research note on Wednesday, August 12th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $51.75.
Get Our Latest Stock Report on CLMT
Calumet Stock Performance
NASDAQ CLMT opened at $58.12 on Tuesday. The stock has a market capitalization of $5.11 billion, a P/E ratio of -37.50 and a beta of 0.72. Calumet, Inc. has a 1 year low of $17.42 and a 1 year high of $59.87. The business's fifty day moving average is $48.00 and its two-hundred day moving average is $38.43.
Calumet (NASDAQ:CLMT - Get Free Report) last posted its quarterly earnings data on Friday, August 7th. The oil and gas company reported ($1.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($1.16). The business had revenue of $1.45 billion during the quarter, compared to analysts' expectations of $1.12 billion. The company's revenue for the quarter was up 40.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($1.70) EPS. On average, research analysts forecast that Calumet, Inc. will post 0.76 earnings per share for the current year.
About Calumet
(
Free Report)
Calumet, formally Calumet Specialty Products Partners, L.P., is a producer of specialty hydrocarbon products and renewable fuels. The company supplies products used in transportation, industrial, commercial and consumer applications, with an emphasis on products that are tailored to specific performance requirements rather than sold solely as commodity fuels.
Its product portfolio includes lubricating oils and additives, solvents, waxes, asphalt and other specialty products, as well as gasoline, diesel and other fuel products.
Read More
Want to see what other hedge funds are holding CLMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Calumet, Inc. (NASDAQ:CLMT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Calumet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet wasn't on the list.
While Calumet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.